Abiopharma

Forte Biosciences Announces Proposed Public Offering

Syndax Announces FDA Priority Review of sNDA for Revuforj® (revumenib) in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia

New Form 4 - Merus N.V. Filed: 2025-06-24 AccNo: 0000950170-25-089442 Size: 8 KB

Notification from cbdMD, Inc.

New Form 11-K - NEOGEN CORP Filed: 2025-06-24 AccNo: 0000950170-25-089430 Size: 3 MB

New Form 11-K - WATERS CORP /DE/ Filed: 2025-06-24 AccNo: 0001193125-25-145691 Size: 131 KB

FDA approve DATOPOTAMAB DERUXTECAN-DLNK

Healthy Extracts Launches STAT10™, Breakthrough CoQ10 and NutrientSupport Formulation for America’s 40 Million Statin Users

New Form 6-K - TRINITY BIOTECH PLC Filed: 2025-06-24 AccNo: 0001178913-25-002220 Size: 160 KB

Best Mid-Range Graphics Cards in 2025: Top Picks

The Top Rated VR Games On Steam (2025)

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Pokimane: Health Update And The Latest On What She’s Up To

New Form 8-K - InMed Pharmaceuticals Inc. Filed: 2025-06-24 AccNo: 0001213900-25-057139 Size: 269 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits